Thermo Fisher Collaborates with NanoPin to Facilitate Infectious Diseases Diagnosis
Shots:
- The companies collaborated to develop highly sensitive liquid chromatography-mass spectrometry (LC-MS)-based workflows for advancing blood-based infectious disease detection technology
- The collaboration leverages NanoPin's diagnostic platform and Thermo Fisher's LC-MS technology to develop clinical assays for infectious disease for determining infection stage and monitor patient response to treatment
- The collaboration may lead to a change in detection & treatment of infectious disease by targeting unmet medical needs of HCPs managing patient care across the globe
Click here to read full press release/ article | Ref: Thermofisher | Image: Market Watch
This content piece was prepared by our former Senior Editor. She had expertise in life science research and was an avid reader. For any query reach out to us at connect@pharmashots.com